Search - tctmd.com

Displaying 261 - 280 of 1291

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2022 News Roundup

L.A. McKeown

August 01, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

Presentation Interventional Complications 2022

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Presenter: Frederick Welt

July 15, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Daily News

Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR

Michael O'Riordan

June 24, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

DasiSimulations: Lifelong Planning for Structural Heart Surgery is Now

Presenter: Lakshmi Prasad Dasi

June 09, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

Worse Survival for Women After Ruptured AAA Repair

L.A. McKeown

May 11, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

Percutaneous Axillary Access: SCAI Calls for Best Practices

Caitlin E. Cox

April 20, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

Advertisement

August 2022 News Roundup

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

DasiSimulations: Lifelong Planning for Structural Heart Surgery is Now

June 2022 News Roundup

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Worse Survival for Women After Ruptured AAA Repair

As TAVI Turns 20, How Has the Heart Team Evolved?

May 2022 News Roundup

Percutaneous Axillary Access: SCAI Calls for Best Practices

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content